We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

240 hedge funds and large institutions have $3.01B invested in Nektar Therapeutics in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 81 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $28.1M | Put options by funds: $7.56M

12% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 25

5% more capital invested

Capital invested by funds: $2.88B → $3.01B (+$131M)

0% more funds holding

Funds holding: 239 → 240 (+1)

0.07% less ownership

Funds ownership: 6.15% → 6.08% (-0.07%)

10% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 81

Holders
240
Holders Change
+1
Holders Change %
+0.42%
% of All Funds
4.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
73
Reduced
81
Closed
25
Calls
$28.1M
Puts
$7.56M
Net Calls
+$20.6M
Net Calls Change
+$21.2M

Top Buyers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
+$8.67M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.45M
3
GPP
Great Point Partners
Connecticut
+$8.09M
4
BG
Bellevue Group
Switzerland
+$7.91M
5
Morgan Stanley
Morgan Stanley
New York
+$6.23M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$29.5M
2
RHJA
Rice Hall James & Associates
California
-$8.49M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$6.21M
4
Norges Bank
Norges Bank
Norway
-$6.1M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
226
Meeder Asset Management
Ohio
$1K -$5.77K -24 -89%
Canada Pension Plan Investment Board
227
Canada Pension Plan Investment Board
Ontario, Canada
$1K – – –
EARNEST Partners
228
EARNEST Partners
Georgia
$1K – – –
IA
229
IFP Advisors
Florida
$1K – – –
JWBC
230
John W. Brooker & Co
California
$1K – – –
OSAM
231
O'Shaughnessy Asset Management
Connecticut
$1K – – –
PCG
232
Private Capital Group
Connecticut
$1K – – –
DFCM
233
Dark Forest Capital Management
Puerto Rico
$1K +$962 +4 New
Nisa Investment Advisors
234
Nisa Investment Advisors
Missouri
$307 -$234K -975 -46%
Walleye Capital
235
Walleye Capital
New York
$235 +$210K +872 New
BBHC
236
Brown Brothers Harriman & Co
New York
$51 – – –
RHJA
237
Rice Hall James & Associates
California
– -$8.49M -32,971 Closed
TCM
238
Tekla Capital Management
Massachusetts
– -$3.1M -12,029 Closed
AF
239
Advisornet Financial
Minnesota
– -$2.93M -11,381 Closed
State of Tennessee, Department of Treasury
240
State of Tennessee, Department of Treasury
Tennessee
– -$2.57M -10,000 Closed
EGM
241
Engineers Gate Manager
New York
– -$2.21M -8,607 Closed
Marshall Wace
242
Marshall Wace
United Kingdom
– -$1.52M -5,917 Closed
MWNA
243
Marshall Wace North America
New York
– -$579K -2,248 Closed
AC
244
Alexandria Capital
Virginia
– -$430K -1,671 Closed
HSBC Holdings
245
HSBC Holdings
United Kingdom
– -$410K -1,581 Closed
DTL
246
Dynamic Technology Lab
Singapore
– -$369K -1,434 Closed
Credit Agricole
247
Credit Agricole
France
– -$351K -1,362 Closed
JG
248
Jefferies Group
New York
– -$343K -1,333 Closed
BC
249
Bridgefront Capital
Texas
– -$280K -1,089 Closed
Connor, Clark & Lunn Investment Management (CC&L)
250
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$270K -1,049 Closed
7 8 9
10
11

NKTR Hedge Fund Activity: Q3 2021 in Review

240 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q3 2021, worth a combined $3.01B — up 4.5% from $2.88B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NKTR positions and 25 closed out — a net gain of 3 holders — while 73 added to existing stakes and 81 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $8.67M. The largest seller was Fidelity Investments, cutting an estimated $29.5M.

  • 240 institutional investors held Nektar Therapeutics (NKTR) as of Q3 2021, up from 239 in Q2 2021.
  • Funds reported $3.01B of Nektar Therapeutics stock for Q3 2021, up 4.5% quarter-over-quarter.
  • 28 funds opened new Nektar Therapeutics positions in Q3 2021 and 25 closed out, a net change of +3 holders.
  • The largest Nektar Therapeutics buyer in Q3 2021 was First Trust Advisors, an estimated $8.67M added.
  • The largest Nektar Therapeutics seller in Q3 2021 was Fidelity Investments, an estimated $29.5M sold.

Based on aggregated 13F filings for Q3 2021.